Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Regeneron Pharmaceuticals (NQ: REGN )

461.57 USD +12.19 (+2.71%)
Official Closing Price Updated: 7:58 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Regeneron Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
4 SPACs for the Future
A rocket company, a 3-D capture software company, and two biotechs are about to hit the public markets. Smart investors can get in now via special purpose acquisition companies. 
Tags GOOGL RDFN GOOG
From Motley Fool
Is BioNTech Stock a Buy?
The key ingredients are here for a multi-bagger over the next decade and beyond. 
Tags REGN NVAX JNJ
From Motley Fool
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GLTO KPTI EYPT
From Benzinga
Sanofi/Regneron's Dupixent Application For Asthma In Children Accepted For FDA Review
TheFDA has accepted for reviewthe supplemental marketing application seeking approval for Dupixent (dupilumab). It is an ... 
Tags Benzinga Market News General
From Benzinga
FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma
From GlobeNewswire News Releases
FDA Accepts Dupixent® (dupilumab) for Review in Children with Moderate-to-severe Asthma
From PR Newswire
Vir Stock Craters On Weak Data For GSK-Partnered Covid Treatment
Emerging data cast doubt on the effectiveness of Vir Biotechnology and GlaxoSmithKline's coronavirus treatment, leading Vir stock to plummet on Wednesday. Shares plunged more than 30%. 
From Investor's Business Daily
ACWV, WM, REGN, GILD: Large Outflows Detected at ETF
Symbols mentioned in this story: ACWV, WM, REGN, GILD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Noteworthy Monday Option Activity: RAD, REGN, HURN
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Rite Aid Corp (RAD), where a total volume of 19,413 contracts has been traded thus... 
Tags Stocks
From Market News Video
Regeneron's Single-Dose REGN1908-1909 Shows Rapid, Durable Benefit In Cat-Allergic Asthma Patients
Regeneron Pharmaceuticals Inc(NASDAQ:REGN) hasannounced detailed resultsfrom a Phase 2 proof-of-concept trial ... 
Tags Benzinga Market News General
From Benzinga
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities ... 
Tags SRPT FDA LLY
From Benzinga
Retail, Tech Earnings, and Berkshire's Surprising Buys
Our Fools talk about fourth-quarter results, as well as the loss of a great CEO. 
Tags AMZN PGRE CVX
From Motley Fool
Regeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma
From PR Newswire
Regeneron's COVID-19 Antibody Cocktail Wins EU Positive Opinion
Regeneron Pharmaceuticals Inc(NASDAQ:REGN) hasreceived a positive opinionfrom European Medicines Agency's ... 
Tags RHHVF CHMP RHHBY
From Benzinga
First Week of REGN August 20th Options Trading
Investors in Regeneron Pharmaceuticals, Inc. (REGN) saw new options become available this week, for the August 20th expiration.. 
Tags Stocks
From Market News Video
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
The battle against Covid-19 is about to get uglier. Coronavirus mutations threaten to undercut a year's worth of work upholding Covid stocks like Pfizer, Moderna and Regeneron Pharmaceuticals. 
From Investor's Business Daily
EMA Issues Advice on Regeneron's Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients
From PR Newswire
Akari Therapeutics' PASylated Nomacopan Shows Promising Action In Animal Studies
Akari Therapeutics Plc(NASDAQ:AKTX)announces new datafrom PASylated nomacopan published in the journal ... 
Tags Biotech News AKTX
From Benzinga
Positive news on COVID vaccines weighs against concerns over new variants
The COVID-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE has proved to be as effective in the real world as it was in clinical trials in the first major study of the two-dose... 
Tags GSK SPX REGN
From MarketWatch
Regeneron To Stop Giving Placebo In COVID-19 Antibody Trial After 'Clear Efficacy'
Following recommendationsfrom the Independent Data Monitoring Committee (IDMC),Regeneron Pharmaceuticals ... 
Tags Benzinga Market News General
From Benzinga
Independent Data Monitoring Committee Finds Clear Efficacy for REGEN-COV™ (casirivimab with imdevimab) in Phase 3 COVID-19 Outpatient Outcomes Trial
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced changes to the Phase 3 trial assessing investigational REGEN-COV™ (casirivimab with imdevimab) in non-hospitalized patients... 
From PR Newswire
Decibel Therapeutics' Hearing Loss Gene Therapy Shows Potential In Preclinical Studies
Decibel Therapeutics Inc(NASDAQ:DBTX)presented preclinical dataof its gene therapy candidate, DB-OTO, for ... 
Tags Market News Hearing loss Health Care
From Benzinga
Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies
FN Media Group Presents USA News Group News Commentary 
From PR Newswire
RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Shares of little-known biopharma firm Relief Therapeutics gained on... 
Tags CDMO LLY RLFTF
From InvestorPlace
Opthea Outlines OPT-302 Pivotal Study Designs In Chronic Eye Disorder
Following consultations with FDA and European Medical Agency,OptheaNASDAQ: OPT) hasfinalized trial designsfor ... 
Tags FDA Health Care Age/Related Macular Degeneration
From Benzinga
Why You Should Keep Your Distance from Ocugen Stock
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Off and on the price chart OCGN stock, today's reality is bleak for... 
Tags MRNA NASDAQ:OCGN,NYSE:PFE,NYSE:JNJ,NASDAQ:REGN,NYSE:AZN,NASDAQ:MRNA PFE
From InvestorPlace
Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11
Health Canada has approvedSanofi’s SA(NASDAQ:SNY) andRegeneron Pharmaceuticals ... 
Tags Market News atopic dermatitis Health Care
From Benzinga
2 Best Pharma Stocks to Buy Right Now
These under-appreciated pharma stocks have the potential to become long-term winners. 
Tags BIIB REGN Market News
From Motley Fool
FDA Approves Regeneron/Sanofi's Libtayo For Front-Line Lung Cancer
The FDA approved expanded use ofRegeneron Pharmaceuticals Inc(NASDAQ:REGN) andSanofi’s ... 
Tags Biotech News A
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.